Sangamo Therapeutics (SGMOQ) Property, Plant & Equipment (Net) Growth (5y) (2015 - 2025)
Powered by 
Analysis
Sangamo Therapeutics (SGMOQ) Property, Plant & Equipment (Net) Growth (5y) (2015 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.28 Bn | 9.43 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.20 Bn | 5.20 Bn | - |
| 3 | Iovance Biotherapeutics | 3.76 Bn | 3.46 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn |
| 5 | uniQure | 3.07 Bn | 3.07 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.67 Bn | 2.67 Bn | - |
| 7 | Precigen | 2.43 Bn | 2.43 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.34 Bn | 1.54 Bn | 251.87 Mn |
| 9 | Vericel | 2.00 Bn | 1.83 Bn | 56.40 Mn |
| 10 | Sangamo Therapeutics | 43.15 Mn | 22.20 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -23.20% |
| Sep 30, 2025 | -15.96% |
| Jun 30, 2025 | -14.24% |
| Mar 31, 2025 | -11.62% |
| Dec 31, 2024 | -9.78% |
| Sep 30, 2024 | -6.31% |
| Jun 30, 2024 | -0.38% |
| Mar 31, 2024 | 3.79% |
| Dec 31, 2023 | -19.34% |
| Sep 30, 2023 | -10.85% |
| Jun 30, 2023 | 10.28% |
| Mar 31, 2023 | 12.25% |
| Dec 31, 2022 | 15.38% |
| Sep 30, 2022 | 45.79% |
| Jun 30, 2022 | 45.00% |
| Mar 31, 2022 | 48.00% |
| Dec 31, 2021 | 51.03% |
| Sep 30, 2021 | 59.76% |
| Jun 30, 2021 | 74.96% |
| Mar 31, 2021 | 70.10% |